Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.
2.

Aldose reductase inhibitor counteracts the attenuated adhesion of human corneal epithelial cells induced by high glucose through modulation of MMP-10 expression.

Tomomatsu T, Takamura Y, Kubo E, Akagi Y.

Diabetes Res Clin Pract. 2009 Oct;86(1):16-23. doi: 10.1016/j.diabres.2009.07.007.

PMID:
19682763
3.

Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor.

Obrosova I, Faller A, Burgan J, Ostrow E, Williamson JR.

Curr Eye Res. 1997 Jan;16(1):34-43.

PMID:
9043821
4.

Effect of aldose reductase inhibitor on corneal epithelial barrier function in galactose-fed dogs.

Kubo E, Mori K, Kobayashi T, Takahashi Y, Yokoi N, Kinoshita S, Kasahara T, Yonezawa H, Akagi Y.

J Ocul Pharmacol Ther. 1998 Apr;14(2):181-90.

PMID:
9572544
5.

Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors.

Jacot JL, Hosotani H, Glover JP, Lois N, Robison WG Jr.

J Ocul Pharmacol Ther. 1998 Apr;14(2):169-80.

PMID:
9572543
6.

Inhibitory effect of orally administered aldose reductase inhibitor SNK-860 on corneal polyol accumulation in galactose-fed rats.

Kubo E, Nakamura S, Tsuzuki S, Takahashi Y, Akagi Y, Mizuno K, Matsubara A.

Graefes Arch Clin Exp Ophthalmol. 1999 Sep;237(9):758-62.

PMID:
10447652
7.

Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.

Robison WG Jr, Jacot JL, Glover JP, Basso MD, Hohman TC.

Invest Ophthalmol Vis Sci. 1998 Sep;39(10):1933-41.

PMID:
9727416
8.

Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose.

Kador PF, Betts D, Wyman M, Blessing K, Randazzo J.

Am J Vet Res. 2006 Oct;67(10):1783-7.

PMID:
17014334
9.
10.
11.

Effect of an aldose reductase inhibitor, CT-112, on healing of the corneal epithelium in galactose-fed rats.

Awata T, Sogo S, Yamagami Y, Yamamoto Y.

J Ocul Pharmacol. 1988 Fall;4(3):195-201.

PMID:
3143793
12.

Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats.

Hosotani H, Ohashi Y, Kinoshita S, Matsumoto T, Awata T.

Curr Eye Res. 1996 Oct;15(10):1005-7.

PMID:
8921238
13.

[Prefeeding of aldose reductase inhibitor inhibits galactose cataract].

Tsuji T, Okamoto S, Ikebe H, Terubayashi H, Akagi Y, Tanimoto T.

Nippon Ganka Gakkai Zasshi. 1993 Apr;97(4):455-9. Japanese.

PMID:
8317365
14.

Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation.

Zhang P, Xing K, Randazzo J, Blessing K, Lou MF, Kador PF.

Exp Eye Res. 2012 Aug;101:36-43. doi: 10.1016/j.exer.2012.05.007.

15.

Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance P-derived peptide (FGLM-NH2) and insulin-like growth factor-1.

Nakamura M, Kawahara M, Morishige N, Chikama T, Nakata K, Nishida T.

Diabetologia. 2003 Jun;46(6):839-42.

PMID:
12764579
16.

The effect of sodium hyaluronate on the expression of gelatinases in rabbit corneal epithelial wound healing.

Sakuma M, Miyachi S, Sakamoto T.

Jpn J Ophthalmol. 2000 Sep-Oct;44(5):475-81.

PMID:
11033124
17.

Effects of aldose reductase inhibitor CT-112 on the corneal epithelial barrier of galactose-fed rats.

Yokoi N, Niiya A, Komuro A, Yokogaki S, Naka H, Awata T, Honma Y, Yamada J, Tei M, Kinoshita S.

Curr Eye Res. 1997 Jun;16(6):595-9.

PMID:
9192169
18.
19.

Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat is prevented by tolrestat.

Forster HG, ter Wee PM, Hohman TC, Epstein M.

Diabetologia. 1996 Aug;39(8):907-14.

PMID:
8858212
20.

A new approach against sugar cataract through aldose reductase inhibitors.

Banditelli S, Boldrini E, Vilardo PG, Cecconi I, Cappiello M, Dal Monte M, Marini I, Del Corso A, Mura U.

Exp Eye Res. 1999 Nov;69(5):533-8.

PMID:
10548473

Supplemental Content

Support Center